Complex Generics: US FDA, Sponsors View Roadblocks Very Differently

 
• By Derrick Gingery
  
The US FDA approval process for complex generic drugs continues to vex sponsors, who want a more predictable timeline. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics